Eligibility:
Or
Purpose: This study helps to identify family members of people with T1D who might have antibodies associated with T1D. Relatives of people with T1D have a 3-4 percent chance of testing positive for antibodies. If participants are found to be antibody positive they will be offered follow up screening and further tests to determine their risk for T1D. Depending on the outcome of those tests, participants may qualify for prevention studies offered by TrialNet.
For more information visit TrialNet on the web.
Coordinators: Juanita O'Brian, CMA, CCRC; Henry Rodriguez, MD
Contact: usfdiabetesresearchc@usf.edu | Phone Number: (813) 974-9817
Eligibility:
Coordinator: Bethany Dunn, RN,BSN
Contact: usfdiabetesresearchc@usf.edu l Phone Number (813) 974-4886
Eligibility:
Purpose: Study to Evaluate Efficacy and Safety of Romosozumab Compared with Bisphosphonates in Children and Adolescents with Osteogenesis Imperfecta
Coordinator: Ponja Hemphill, RN
Contact: CRC-health@usf.edu
TEDDY Study compares characteristics of children diagnosed with type 1 diabetes before and after age 6
New findings from the international The Environmental Determinants of Diabetes in the Young (TEDDY) study add to the growing body of evidence indicating that type 1 diabetes is not a single disease.
Click here to view full article.
USF Awarded Four-Year, $69.9 Million NIH Grant to Continue Type 1 Diabetes Research
The Environmental Determinants of Diabetes in the Young study is led by USF Health’s Jeffrey Krischer, who has built a worldwide epidemiological hub for T1D research at USF.
Click here to view full article.
Nature highlights USF Health-led TEDDY study as a diabetes research milestone
Click here to view article.
USF Health Informatics Institute contributes to new NIH study indicating that measuring gene expression changes over time may help predict type 1 diabetes progression in at-risk children, and lead to earlier diagnosis of the autoimmune disease.
Click here to read the full article.